Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 282, Issue 14, Pages 10833-10839Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M611507200
Keywords
-
Categories
Funding
- Intramural NIH HHS Funding Source: Medline
- NHLBI NIH HHS [HL073935] Funding Source: Medline
Ask authors/readers for more resources
Ca2+-calmodulin-dependent protein kinase II ( CaMKII) is expressed in many mammalian cells, with the delta isoform predominantly expressed in cardiomyocytes. Previous studies have shown that inhibition of CaMKII protects cardiomyocytes against beta(1)-adrenergic receptor-mediated apoptosis. However, it is unclear whether activation of CaMKII is sufficient to cause cardiomyocyte apoptosis and whether CaMKII signaling is important in heart muscle cell apoptosis mediated by other stimuli. Here, we specifically enhanced or suppressed CaMKII activity using adenoviral gene transfer of constitutively active ( CA-CaMKII delta C) or dominant negative ( DN-CaMKII delta C) mutants of CaMKII delta C in cultured adult rat cardiomyocytes. Expression of CA-CaMKII delta C promoted cardiomyocyte apoptosis that was associated with increased mitochondrial cytochrome c release and attenuated by co-expression of Bcl-XL. Importantly, isoform-specific suppression of CaMKII delta C with the DN-CaMKII delta C mutant similar to nonselective CaMKII inhibition by the pharmacological inhibitors ( KN-93 or AIP) not only prevented CA-CaMKII delta C-mediated apoptosis but also protected cells from multiple death-inducing stimuli. Thus, activation of CaMKII delta C constitutes a common intermediate by which various death-inducing stimuli trigger cardiomyocyte apoptosis via the primary mitochondrial death pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available